Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
927K
-
Shares change
-
+86.5K
-
Total reported value, excl. options
-
$92.1M
-
Value change
-
+$8.55M
-
Number of buys
-
10
-
Number of sells
-
-4
-
Price
-
$99.45
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q4 2023
23 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q4 2023.
Moderna, Inc. - COMMON STOCK (MRNA) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 927K shares
of 385M outstanding shares and own 0.24% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (45.7M shares), VANGUARD GROUP INC (33.9M shares), BlackRock Inc. (25.3M shares), STATE STREET CORP (14.6M shares), Flagship Pioneering Inc. (9.67M shares), Theleme Partners LLP (7.35M shares), WELLINGTON MANAGEMENT GROUP LLP (7.23M shares), GEODE CAPITAL MANAGEMENT, LLC (6.55M shares), FMR LLC (6.39M shares), and GOLDMAN SACHS GROUP INC (4.55M shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.